Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Pathologic Processes » Disease Attributes » Critical Illness
Description
A disease or state in which death is possible or imminent. MeSH
Hierarchy View
Phase 4 Indicated Drugs (51)
Phase 3 Indicated Drugs (23)
Phase 2 Indicated Drugs (35)
Phase 1 Indicated Drugs (4)
Other Experimental Indicated Drugs (31)
Organization Involved with Phase 4 Indications (61)
Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta
Katholieke Universiteit Leuven
King Edward Medical University
National Heart, Lung, and Blood Institute (NHLBI)
Organization Involved with Phase 3 Indications (65)
Assistance Publique - Hôpitaux de Paris
Australian and New Zealand Intensive Care Society Clinical Trials Group
Canadian Critical Care Trials Group
Canadian Institutes of Health Research (CIHR)
Case Western Reserve University
Council of Scientific and Industrial Research, India
Hospital Nossa Senhora da Conceicao
Medical Research Institute of New Zealand
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Shahid Beheshti University of Medical Sciences
Swiss National Science Foundation
Organization Involved with Phase 2 Indications (50)
Beijing Institute of Pharmacology and Toxicology
Centers for Disease Control and Prevention, China
Children's National Medical Center
National Institute for Health Research, United Kingdom
National Institute of Allergy and Infectious Diseases (NIAID)
Organization Involved with Phase 1 Indications (13)
Organization Involved with Other Experimental Indications (46)
Alkarkh Health Directorate-Baghdad
All India Institute of Medical Sciences
Jawaharlal Institute of Postgraduate Medical Education and Research
Moorgreen Hospital, Southampton
National Nutrition and Food Technology Institute
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
